Sjögren’s Syndrome News

Patients with Sjögren’s syndrome and gastrointestinal disease were more likely to have elevated levels of fecal calprotectin compared to patients without gastrointestinal disease, according to researchers from Sweden.

Patients with Sjögren’s syndrome tended to have higher levels of vitamin D compared with healthy control participants in a recently presented study, which found no association with antibodies and levels of vitamin D.

The American Autoimmune Related Diseases Association has released a report available to the public that addresses topics in autoimmune diseases, research and patient information following a one-day autoimmune summit in Washington, D.C., that involved about 20 researchers.

Discussions surrounding fatigue and its impact are not routinely raised with patients with rheumatic diseases and patients may face significant barriers to communication about the impact of fatigue, according to researchers from the United Kingdom.

Sjögren’s syndrome is an autoimmune disorder characterized primarily by dry eyes and mouth, which is caused by a person’s white blood cells attacking moisture glands, such as those that produce tears and saliva. People with Sjögren’s syndrome also may have joint pain and fatigue.

Reactivation of the Epstein-Barr virus may be common in patients with Sjögren’s syndrome and may be involved in the progression of gland dysfunction or damage, according to researchers in Warsaw, Poland.

Researchers appear to have identified novel serum proteins that may serve as biomarkers for salivary dysfunction in patients with primary Sjögren’s syndrome, according to recently presented study data.

Researchers from the Karolinska University Hospital in Stockholm recently presented data that showed men with primary Sjögren’s syndrome tended to have higher levels of autoantibodies and a greater number of extraglandular manifestations of disease than women.

Royal Philips announced the release of Lumify, a subscription-based smart device ultrasound solution for purchase by licensed U.S. health care providers and organizations.

SAN FRANCISCO — Levels of fatigue and depression, followed by anxiety and pain, were predictive of a reduction in overall quality of life, the ability to perform daily activities and the ability to take on life roles by patients with primary Sjögren’s syndrome, according to recently presented research.